Learn which products consumers “fire” after trying CBD and cannabis.
Image used with permission from The Parent Company.
Cannabis and CBD: The Role Within Health and Wellness
2021: Aclara Research and Ipsos
Aclara collaborated with Ipsos to understand how, why and when consumers were using cannabis and CBD products - identifying need states that impact 100 Million adults.
Projected to reach $41 Billion in sales by 2025, legal cannabis disrupts consumer demand for traditional categories and retailer trips - including alcohol, OTC medications, prescription drugs and wellness products.
In this study of over 1,000 consumers, over 50% stopped or reduced their usage of alcohol, OTC, prescription drugs and supplements.
This 100 page study contains answers to key questions impacting companies in the Wellness, OTC Medications, Prescription Drugs and Beverage/ Alcohol Industries:
Are your products used as substitutes or complements to cannabis and CBD?
Recognize how Cannabis and CBD Solve Jobs to Be Done
Identify Category Triggers and Adoption
Understand Consumer Usage and Shopping Behavior Shifts
Methodology and Timing
Qualitative
In 2021, we explored qualitative insights across key focus areas and invited members to respond in a pop up online community.
Topics included:
Why are people using cannabis in their daily lives?
How are people changing and shifting their health and wellness routines?
How did they first consider and use THC or CBD products?
Quantitative
We fielded a 38 question online survey across 1,003 adult respondents across recreational and medical states.
We collected quantitative data across the following topics:
Reasons for cannabis and CBD use
Understand product forms and dosing levels
Understand the usage occasions
Demand impact on traditional CPG products
Household spending and channels shopped
